title: New drugs: simeprevir, sofosbuvir, and dolutegravir sodium.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Zhimeng Jenny
authors.initials: ZJ
authors.lastname: Jin
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D017277:Drug Approval; D006526:Hepatitis C / Q000188:drug therapy; D006575:Heterocyclic Compounds, 3-Ring / Q000627:therapeutic use*; D006801:Humans; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D000069616:Simeprevir; D000069474:Sofosbuvir; D013449:Sulfonamides / Q000627:therapeutic use*; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000099226:Dolutegravir
chemical_list: D000998:Antiviral Agents; D006575:Heterocyclic Compounds, 3-Ring; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D000069616:Simeprevir; D000069474:Sofosbuvir; D013449:Sulfonamides; D014542:Uridine Monophosphate; D000099226:Dolutegravir